Guinea-Bissau vs Hong Kong: The number of people with susceptibility test result for rifampicin
Guinea-Bissau
1,934
in 2021
Hong Kong
2,181
in 2021
Guinea-Bissau rank
48th
Hong Kong rank
45th
The number of people with susceptibility test result for rifampicin over time
- Guinea-Bissau
- Hong Kong
How they compare
Hong Kong currently reports 2,181 against 1,934 in Guinea-Bissau, a difference of 247.
That makes Hong Kong's figure about 1.1 times Guinea-Bissau's.
Across all 5 years both countries report, Hong Kong has been ahead every year.
Guinea-Bissau ranks 48th and Hong Kong ranks 45th of 155 countries.
Hong Kong has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Hong Kong | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 20.67 | 2,387 | 2,366 | Hong Kong |
| 2020s | 1,573 | 2,143 | 570 | Hong Kong |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Guinea-Bissau or Hong Kong?
- Hong Kong, at 2,181 against 1,934 in Guinea-Bissau as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Guinea-Bissau and Hong Kong?
- 247, with Hong Kong ahead.
- How many years of comparable data are there for Guinea-Bissau and Hong Kong?
- 5 years are reported by both, from 2017 to 2021.
- How do Guinea-Bissau and Hong Kong rank globally for the number of people with susceptibility test result for rifampicin?
- Guinea-Bissau ranks 48th and Hong Kong ranks 45th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.